Trial Profile
A single blind, five period, randomized, placebo-controlled crossover food effect study to evaluate the pharmacokinetics and pharmacodynamics of ORMD-0801
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Jun 2018
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 27 Jun 2018 New trial record